MacBeath Gavin — SEC insider filings
SEC reporting owner CIK 1738082. 8 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2021-09-22 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 5,000 shares, $31,097 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 4,943 shares @ $6.22 ($30,744) in TScan Therapeutics, Inc., filed 2021-09-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TScan Therapeutics, Inc. (TCRX) | Chief Executive Officer, Director | 8 | 2 legs · 5,000 sh · $31,097 | — | 8 |
Insider filings — MacBeath Gavin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 1,000,000 @ $0 | EDGAR |
| 2026-01-22 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 1,165,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 160,000 (derivative) @ $0 · Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 1,121,300 (derivative) @ $0 | EDGAR |
| 2023-02-06 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-07-27 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2021-09-22 | 4 | TScan Therapeutics, Inc. (TCRX) | Purchase (P): 4,943 @ $6.22 · Purchase (P): 57 @ $6.19 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-09-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1738082 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs